chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after injection: sweating, throat and ears closing, ears ringing, dizziness/lightheaded, spotty/white vision, shaking Next day: intense pain in left arm (could not move my body without sharp pain), fever of 101, chills/shaking, sweating, nausea, chest pain, ringing in the ears
C/o dizziness, diaphoretic. Reclined to floor BP 102/58 P 78 felt better reclining. Observed for 10 min. BP 110/68 P 68 sat up in chair- felt dizzy-reclined to floor- felt better after 10 min- symptoms subsided & left clinic.
headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Concomitant and treatment medications were not provided.
I had the vaccine at approximately 7:35 AM and by 1:30 PM I was not running a temperature, however, it felt like my insides were going to burn as my core felt like it was on fire. I still feel like more core is on fire, but it has subsided and is less concerning as it was on Friday, 3/26/2021, and Saturday, 3/27/2021  My eyes became sensitive to light on Friday, 3/26/2021 night and my eyes are still sensitive especially to artificial lighting. Natural light hurts as well but is more tolerable.  My heart rate definitely increased Friday, 3/26/2021 through Saturday, 3/27/2021 however I did not experience the other symptoms on the critical list (such as inability to breathe) therefore did not go to the hospital.  I suffered from muscle weakness on Friday, 3/262021, and Saturday, 3/27/2021. The muscle weakness was only in my legs.
Local 8 days ago had TDAP   Getting series Had # 2 dose  Last week. The next day got red ane swollen. 1 st TDAP shot 2018  No rxn.    Warm area x 4 days. Now better   Iced   No SOB  No mouth swelling. Slight swollen.now + pain Lt upper arm  Took Tylenol for temp 100.2 1 week ago.   Exam  No swelling slight tender  No erythema  Lt upper arm
This spontaneous report was received from a physician via a company representative and refers to 2 unspecified patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concurrent conditions was reported. On unspecified dates, the patients was vaccinated with a GARDASIL 9 (lot number, expiration date, dose, route and frequency were not provided) and experienced syncope. The outcome of syncope is unknown. Causality assessment was not provided. Additional information has been requested.
chills; headache; lethargic; This is a spontaneous report from a contactable consumer, the patient. This is the first of two reports. An 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Apr2021 15:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Oct2020 (unspecified if ongoing), notes: previously had Covid in Late October, Prior to vaccination, was the patient diagnosed with COVID-19 : Yes. There were no concomitant medications. The following information was reported: CHILLS (non-serious) with onset 2021, outcome "recovered" (2021), described as "chills"; HEADACHE (non-serious) with onset 2021, outcome "recovered" (2021), described as "headache"; LETHARGY (non-serious) with onset 2021, outcome "recovered" (2021), described as "lethargic". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, headache, lethargy.  Additional information: Patient had no known allergies to food, medications or other products. Patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, after the first vaccine, patient experienced chills, a headache and was lethargic and it lasted for 24 hours. On an unknown date in Apr2021, the patient underwent antibody test and the result was positive for short term and long-term antibodies. The clinical outcome of the events chills, a headache and was lethargic were recovered on an unknown date in 2021.The patient did not receive treatment for the reported events.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Days 1-4 unable to lift right arm  Night 2 fatigue, body aches, headache, sore throat Day 7 right armpit pain
Patient had shortness of breath 8/8/22 and tested + for covid 8/10/22 , had abnormal CXR according to forms and also had h/o smoking , chronic lung disease, htn.    admitted to Hospital.    Deceased 8/19/22.
Swelling to eyes and right ear 10 min. after vaccination. DTap, MMR, and IPV-(-)distress or wheeze, O2 sat 96% on RA 1 tsp. BENADRYL, 0.15 ml epinephrine 1:1000 Sq and 2 tsp ORAPRED. Went to ER for evaluation and observation.
Pt received vaccine and two days later displayed reduced appetite, shortness of breath, chills, and cough productive of grayish thick sputum. Pt presented to hospital 5 days later (7 days after vaccination) with these symptoms, deemed to be in acute on chronic hypoxic/hypercarbic respiratory failure.
12:30 mobile team alerted me to head out to see a patient, once I arrived the mobile team told me he reported to have a sudden new onset of chest pain and body aches12:32 Called EMS to the site12:36 Vitals were taken Blood pressure-148/80, Pulse-94, Temperature- 98.1F, Respirations-14, SPO2-98%, pain 4/10 numeric scale chest area that was sharp, patient was A&Ox4 person, place, time and situation, no labored breathing, equal rise of chest wall, denies shortness of breath, skin pink with no discoloration, patient was able to follow commands when performing the assessment, will continue to monitor until the arrival of EMS 12:39 EMS arrived at the site 12:43 EMS took the patients vitals Blood pressure-137/92, Pulse- 95,Respiations-15, Spo2-99%, pain 0/10 on the numeric scale, patient claims that his chest pain has resolved, denies shortness of breath, EKG was within the normal sinus rhythm when the EMS performed it, equal rise of chest wall, no labored breathing, skin pink with no discoloration, A&O x 4 to person, place, time, and situation, patient was able to answer and follow all commands of the EMS team, the patient denied treatment and transportation to the hospital by the EMS team,  12:48- EMS left the site, provide education the patient has sudden chest pain again and or trouble breathing to call 911, patient verbalized understanding
Myocardial infarction; This literature-non-study case was reported in a literature article and describes the occurrence of MYOCARDIAL INFARCTION (Myocardial infarction) in a 96-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   LITERATURE REFERENCE:    No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYOCARDIAL INFARCTION (Myocardial infarction) (seriousness criteria hospitalization and medically significant). The patient was hospitalized for 3 days due to MYOCARDIAL INFARCTION. At the time of the report, MYOCARDIAL INFARCTION (Myocardial infarction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product and treatment medication use were not provided. Authors comment: We are unable to attribute the cause of the patient's MI to the Moderna vaccine unless further data are published. As healthcare providers, we need to be aware of attempts to correlate bad outcomes with the vaccine without substantiated data, and anticipate patient questions that may arise from these reports. Any research on the topic should be written carefully and avoid overstating the findings.   Company comment: This literature non-study case concerns a 96-year-old female patient with no medical history reported, who experienced the unexpected serious (hospitalization and medically significant) event of Myocardial infarction after mRNA- 1273 Moderna vaccine. The onset of the event occurred one hour after the first dose of mRNA- 1273 vaccine. The patient was medically managed and discharged three days later. No further information is available at this moment. Patient´s elderly age remains a confounder. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.; Sender's Comments: This literature non-study case concerns a 96-year-old female patient with no medical history reported, who experienced the unexpected serious (hospitalization and medically significant) event of Myocardial infarction after mRNA- 1273 Moderna vaccine. The onset of the event occurred one hour after the first dose of mRNA- 1273 vaccine. The patient was medically managed and discharged three days later. No further information is available at this moment. Patient´s elderly age remains a confounder. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.
Impetigo; Sore arm; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of IMPETIGO (Impetigo) and VACCINATION SITE PAIN (Sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On 12-Feb-2021, the patient experienced IMPETIGO (Impetigo). On 11-Feb-2021, VACCINATION SITE PAIN (Sore arm) had resolved. At the time of the report, IMPETIGO (Impetigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Information has been received from a health professional concerning a 4.5 year old male who in 2001 was vaccinated SQ with a 0.5cc dose of Varicella Virus Vaccines live.  There was no concomitant medication.  It was reported that the patient "just" on approximately 21 FEB 2005 broke out with chicken pox.  He was treated with acetaminophen and ibuprofen.  No labs were done and the patient is recovering.  Unspecified medical attention was sought.  No product quality complaint was involved. Additional information is not expected.
Complaining of pain in both knees, warm to touch. Rash noticeable on both arms (inner aspect) and also on both legs.
Chills; Sore shoulder; A spontaneous report was received from a consumer, concerning a 90-year-old male patient, who received Moderna's COVID-19 vaccine and experienced chills /and sore shoulder/myalgia.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 10 Feb 2021, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot number unknown) via intramuscular route for COVID-19 infection prophylaxis.   On 10 Feb 2021, after unknown dose of vaccine, the patient experienced chills and sore shoulder. No treatment medication was reported.  Action taken with mRNA-1273 in response to the event was unknown.  The outcome of the event(s), chills and sore shoulder was considered to be unknown at the time of this report.
Immediate reaction - redness, tenderness, swelling about 10 cm. Itchy area. Administered BENDARYL, applied ice pack. Observed 20 min. No systemic reaction occurred.
Onset 1/2 - 1 hr - mouth felt funny, weak, achy. 6 hrs - heart racing, body aching, scared, started to pray. Next day - Body aching, skin hurt, worn out. Symptoms resolved - 24 hours
Client in clinic 1/5/11 reporting pink area about the size of a 50 cent piece on an anterior part of upper left arm 1/11/11 - no redness or pink area at sites of injection. States she had a "high fever" but did not take her temp; also c/o pain in her upper arm. Currently still c/o pain in upper arm & shoulder. No redness noted. Left arm slightly larger than right in appearance but client states that it is always like that. States she did not take any pain relievers. When symptoms started. To take OTC pain reliever & use ice compresses. RTC or see PHCP if symptoms persist.
Information received on 21MAR2014 from an Investigator. A 32 year old female (gravida 1, para 0) experienced a missed abortion. On an unspecified date in December 2013, the female received a primary dose of BIOTHRAX (Lot FAV343), along with smallpox and typhoid vaccine, 4 days after last menstrual period and 10 days prior to estimated date of conception. She also received Influenza Split-preservative free vaccine on an unspecified date in November 2013. In JAN2014, the subject was determined to be pregnant (22 days after vaccination). Subsequently, she was contacted by the Investigator for possible enrollment in an ongoing pregnancy registry. Electronic medical records revealed that she had experienced a missed abortion at estimated gestational age (EGA) 11+1 weeks. An ultrasound at that time demonstrated crown rump length (CRL) of 0.65 cm, 0.48 cm with no cardiac activity and a collapsing gestational sac. She underwent a dilatation and curettage, and was treated with oxycodone hcl / acetaminophen, ibuprofen and methylergonovine maleate. By MAR2014, she had recovered. Relevant medical history - none. Concomitant medications - none. The Investigator/Reporter felt that the event could possibly be related to vaccine administration.
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medication was provided.  It was reported that patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine was unknown and reported that 190 patients (9 different lot numbers) received a vaccine past the beyond used by date.   Treatment medication was not provided by the reporter.  This case contains the information of 5th patient out of 190 patients as described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:MASTER  CASE
Information has been received from a licensed visiting nurse concerning a 13 year old male who on 17-JAN-2006 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient developed a non-serious localized injection site reaction described as a mild rash. It was unspecified if medical attention was sought. The rash resolved three days after receiving the vaccination. No further information was provided. Additional information is not expected. This is one of several reports from the same source.
Hives @ injection site, raised, red, hot, multiple. ORAPRED given and BENADRYL cream.
This is a spontaneous report received from a contactable consumer (patient). A patient (no qualifiers provided) received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), on Mar 2021, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. The patient had increased blood glucose/elevated blood sugar, onset Mar 2021, with outcome of unknown. Relevant laboratory tests and procedures available in the appropriate section. Additional information: Consumer stated the first Pfizer shot was received on Thursday of last week. They have been watching their blood sugar and the sugars have been elevated. Consumer wanted to know if the vaccine affected blood sugar, especially since their blood sugar has been elevated ever since the vaccination. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
My COVID-19 symptoms started early morning on 05/20/2023 with congestions.  I thought it was allergies.  I took Aleve and went to sleep since I was tired.  Around 11:00AM I had a low grade fever, head aches, and fatigue. It lasted till the evening.  At night I had a sore throat, fever, headaches, chills, and body aches. I was extremely tired. I had cough which started on 05/21/2023  I called my doctors office on Sunday and did a telehealth with a PA who prescribed me Paxlovid for 5 days. As of today I am feeling much better than before. I took a test yesterday 05/24/2023 which was positive.
Pt. presented to office with scattered petechia on proximal UE, proximal LE, diffusely on anterior and posterior trunk, very few on ankles and dorsal surface feet; peeling of skin on periphery of trunk 2 days after receiving vaccine. Rash was itchy. Pt. also with headache , but resolved by time of visit. Afebrile, no other s/s of illness, is well-appearing. 3 days after vaccine, rash was not progressing, but not resolving. No other new s/s.
Patient passed out 5 minutes after receiving vaccine. 12 hours later the patient had severe chest pain and went to the ED. He received a ketorolac shot there and returned home. 36 hours later, red dots were noticed on the patients feet and ankles (appeared to be petechiae). No other s/sx of bleeding but extreme fatigue, nausea, head fogginess, etc. has been experienced over the past 4-5 days.  Patient w/ no PMH of any significance.
Vaccine was administered on 10/8/19, child had a seizure on 10/9/19 at 8AM. Child was known to have a temp of 101.8 in the ED.
Hives first appeared on evening of 9/28 around the injection site of HPV vaccine #2 administered the evening prior.  On the morning of 9/29/16 the hives spread to the rest of her arm.  When the patient called the clinc to report the reaction today (9/29), the patient was advised to take Benadryl or antihistamine.
Arm soreness; slight aches; slight fatigue; Large lump (lymph node maybe) under arm pit left arm; This is a spontaneous report from a contactable other health professional (patient). A 47-year-old male patient received first dose of BNT162B2 (Lot number: Eh9899) intramuscularly in left arm on 21Dec2020 10:00 at single dose for COVID-19 immunization. Medical history included COVID-19 from an unknown date and unknown if ongoing (COVID prior vaccination: Yes). There were no concomitant medications. The patient experienced arm soreness, slight aches, slight fatigue, large lump (lymph node maybe) under arm pit left arm all on 23Dec2020 03:00 AM. Treatment was not received. The patient underwent lab tests and procedures which included COVID test: COVID on an unspecified date. The outcome of events was not resolved. Facility where the most recent COVID-19 vaccine was administered in hospital. Prior to vaccination, the patient was diagnosed with COVID-19.
I had an incredibly fast heart rate, even while laying down for a long time. I fainted after walking less than a half mile to get food
Hospitalized 8/17/22-8/20/22 weakness, decreased appetite, SOB, body aches, diarrhea, fatigue, fever, chills, cough, abdominal pain, dehydration, transaminitis,
Vaccination was received on 4/28/2009 in Left Arm.  Client was brought back in the HD on 05/01 with very red swollen LA, with a temperature of 100.2.  Mother states he could not move arm without extreme pain, and could not touch.  Was instructed to give child Advil or Tylenol for pain and apply ice packs to area and to take to PMD if worse.  Fever increased to 101.8 with child co increase inpain.  He was taken to his PMD for care and was given Keflex 500mg 1 po tid for 10 days.  PMD said he had a Staph infection.  When asked what test was performed to confirm this,the mother did not know.
patient never felt so sick in his/her life; Initial information received on 15-Jan-2021 regarding an unsolicited valid non-serious social media case received from a consumer (patient).  This case involves a patient of an unknown age and gender who never felt so sick in his/her life, after receiving INFLUENZA VACCINE.  The patient's medical treatments, vaccinations, concomitant medications and family history were not provided.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   On an unknown date years ago, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer batch number and expiry date not reported via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient never felt so sick in his/her life (illness) non-serious event (Unknown latency) following the administration of INFLUENZA VACCINE.  Reporter said so now I will not get the flu or any other shots.  It is unknown if the patient experienced any additional symptoms/events.  Medication Details and reason for taking the medicine: Flu.  It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment.  The outcome of event was unknown, at the time of reporting.  There will be no information on the batch number for this case.
I received the COVID vaccine on March 11, 2021. That same day arm was completely swollen, low-grade fever, chills and small headache. On March 15, 2021 I started with a top left back pain (same side as injection) where is it painful to move and difficult to breathe deeply. I'm not completely sure if this is related to the COVID vaccine but it is on the same side of the site of injection.